fda warning bpc-157 unapproved drug marketing warning letter panel backs compounded BPC-157, KPV peptides in win for RFK Jr A health warning about unregulated
A health warning about unregulated peptides has been issued by Australia's drug regulator but doctors say more action is needed. Reporting by national health equity reporters Caitlyn Gribbin and Rachel Carbonell, ABC FDA is moving to restrict mass marketed compounded GLP 1 products that aren't FDA approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified FDA Warns Companies for Illegally Selling Food and Beverage Products that Contain CBD FDA The growing popularity of peptides, many of which have not been authorized by the Food and Drug Administration, prompted Alabama's medical board to warn against prescribing them. (Full story below.) As interest in weight loss medications and peptide therapies continues to grow, doctors are warning consumers about the risks associated with unregulated peptides that are increasingly being marketed online for weight loss
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
